CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities:
Net income	$ 11,478	$ 10,630
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,100	3,001
Amortization on right-of-use assets	1,543	2,505
Provision (Recovery) for bad debts	5,103	1,711
Deferred income tax - net	1,712	2,481
Compensatory element of stock issuances	83
Stock issued for costs and expense	1,941	1,990
Abandoned patents	1
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable	(9,551)	(6,808)
Notes receivable	36	22
Contract assets	(65)	372
Inventories	(323)	23
Income tax receivable	671
Prepaid expenses and other current assets	424	570
Other assets	(1)	(142)
Increase (decrease) in operating liabilities, net:
Accounts payable	(189)	(175)
Other current liabilities	(1,827)	(193)
Operating lease liabilities	(1,168)	(2,216)
Financing lease liabilities	(25)
Customer deposits	183	56
Other liabilities	14	105
Net cash provided by operating activities	13,140	13,932
Cash Flows from Investing Activities:
Purchases of property and equipment	(2,942)	(6,601)
Purchase of imaging facility	(1,123)
Proceeds of short term investment		15,063
Cost of patents	(108)	(79)
Net cash (used)/provided by in investing activities	(4,173)	8,383
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(73)	(33)
Proceeds from debt	63
Distributions to noncontrolling interests	(4,950)	(5,145)
Net cash used in financing activities	(4,960)	(5,178)
Net Increase in Cash and Cash Equivalents	4,007	17,137
Cash and Cash Equivalents - Beginning of Period	36,802	13,882
Cash and Cash Equivalents - End of Period	$ 40,809	$ 31,019